Pubblicazioni

ATTIVITA’ SCIENTIFICA

 

 

Pubblicazioni

 

1-Manservigi R., Grossi M.P., Gualandri R., Zucchini S., Marconi P.C. and Cassai E.

Herpes Simplex virus glycoproteins and their role. In: “Fifth International Symposium on Clinical and Enviromental Microbiology”, A. Turano (ed.). Brescia, Brixia Academic Press, pp. 69-78. 1992.

 

2-Grossi M.P., Caputo A., Zucchini S., Bozzini R., Marconi P.C., Manservigi R., Barbanti-Brodano G. and Balboni P.G.

Molecular approaches tat inhibit HIV-1 tat expression and functions. In: “Generation of Antibodies by Cell and Gene Immortalizazion”, C. Terhorst, F. Malavasi & A. Albertini (eds.), Year Immunol. vol. 7.pp. 199-204. Basel, Karger,1993.

 

3-Caputo A., Balboni P.G., Manservigi R., Bozzini R., Marconi P.C., Rossi C., Zucchini S., Barbanti-Brodano G. and Grossi M.P.

Possibile approaches of gene therapy of AIDS. Minerva Biotec. 5: 322-325, 1993.

 

4-Caputo A., Grossi M.P., BalboniP.G., Bozzini R., Zucchini S., Marconi P.C., Manservigi R. e Barbanti- Brodano G.

Effetto di un mutante transdominante negativo sulla riattivazione del virus dalla latenza. L’Igiene Moderna 100: 449-465, 1993.

 

5-Balboni P.G., Bozzini R., Zucchini S., Marconi P.C., Grossi M.P., Caputo A., Manservigi R. and Barbanti-Brodano G.

Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant. J. Med. Virol. 41: 289-295, 1993.

 

6-Caputo A., Grossi M.P., Balboni P.G., Bozzini R., Marconi P.C., Zucchini S., Barbanti-Brodano G. and Manservigi R.

Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transominant negative mutant. In: “ECB6: Proceedings of the 6th European Congress in Biotechnology”, pp. 689-693, L. Alberghina, L. Frontali & P. Sensi (Eds.). Amsterdam, Elsevier Science Publ.,1994.

 

7-Argnani R., Zucchini S., Focher F., Verri A., Spadari S. and Manservigi R.

Herpes simplex virus type-1 uracil-DNA glycosylase: cloning and characterization. Minerva Biotec. 7: 116-119, 1995.

 

8-Argnani R., Focher F., Zucchini S., Verri A., Wright G. E., Spadari S. and Manservigi R.

Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in E. coli, Biochemical Characterisation and Selective Inhibition by 6-(p-n-Octylanilino)Uracil. Virol. 211: 307-311,1995.

 

9-Chiarantini L., Argnani R., Zucchini S., Stevanato L., Zabardi P., Grossi M.P., Magnani M. and Manservigi R.

Red Blood Cells as Delivery System for recombinant Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein B: Immunogeniticy and Protection in Mice. Vaccine, 1997 Feb; 15 (3): 276-80.

 

10-Laquerre S., Argnani R., Anderson D.B., Zucchini S., Manservigi R., Glorioso J.C.

 Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol. 1998 Jul; 72(7): 6119-30.

 

11-Marconi P., Simonato M., Zucchini S., Bregola G., Argnani R., Krisky D., Glorioso J. C., Manservigi R.

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo. Gene Ther. 1999 May; 6(5): 904-12.

 

12-Bregola G., Dumont Y., Fournier A., Zucchini S., Quirion R., Simonato M.

Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy. Neuroscience. 2000 Jul 1; 98(4): 697-703.

 

13-Bregola G., Frigati L., Zucchini S. and Simonato M.

Different patterns of induction of fibroblast growth factor-2 and brain-derived neurotrophic factor messanger RNAs during kindling epileptogenesis, and developtment of a herpes simplex vector for fibroblast growth factor-2 gene transfer in vivo. Epilepsia 2000,41.Suppl.6:S122-6

 

14-Simonato M., Bregola G., Armellin M., Del Piccolo P., Rodi D., Zucchini S., Tongiorgi E.. Dendritic Targeting of mRNAs for plasticities  genes in experimental models of temporal lobe Epilepsy. Epilepsia 2002,43.Suppl.5:153-8.

 

15-Bregola  G., Zucchini S., Frigati  L., Candeletti S., Romualdi P., Reinscheid R., Simonato M. Invovement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. Epilepsia 2002,43.Suppl.5:18-9

 

16-Rodi D, Polidori C, Bregola G, Zucchini S, Simonato M, Massi M

Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats.

Brain Res. 2002 Dec 13;957(2):354-61.

 

17-Zucchini S, Buzzi A, Bergamaschi M, Pietra C, Villetti G, Simonato M.

Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.

Neuroreport. 2002 Nov 15;13(16):2071-4.

 

18-Bregola G, Zucchini S, Rodi D, Binaschi A, D'Addario C, Landuzzi D, Reinscheid R, Candeletti S, Romualdi P, Simonato M

Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.

J Neurosci. 2002 Nov 15;22(22):10030-8.

 

19-Barbieri M, Bregola G, Buzzi A, Marino S, Zucchini S, Stables JP, Bergamaschi M, Pietra C, Villetti G, Simonato M.

Mechanisms of action of CHF3381 in the forebrain.

Br J Pharmacol. 2003 Aug;139(7):1333-41.

 

20-Binaschi A, Zucchini S, Bregola G, Rodi D, Mazzuferi M, Reinscheid RK, Simonato M. Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice.

Neuroreport. 2003 May 6;14(6):825-7.

 

 

21-Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo G

Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.

Eur J Neurosci. 2003 May;17(9):1987-90.

 

22-Mela F, Marti M, Ulazzi L, Vaccari E, Zucchini S, Trapella C, Salvadori S, Beani L, Bianchi C, Morari M.

Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur J Neurosci. 2004 Mar;19(5):1317-24

 

23-Tongiorgi E, Armellin M, Giulianini PG, Bregola G, Zucchini S, Paradiso B, Steward O, Cattaneo A, Simonato M.

Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis.
J Neurosci. 2004 Jul 28;24(30):6842-52

 

24-Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo' G.

Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jun;369(6):547-53.

 

25-Carra G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
J Pharmacol Exp Ther. 2005 Mar;312(3):1114-23.

 

26-Marconi P, Zucchini S, Berto E, Bozac A, Paradiso B, Bregola G, Grassi C, Volpi I, Argnani R, Marzola A, Manservigi R, Simonato M.

Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo. Gene Ther. 2005 Apr;12(7):559-69.

 

27-Manservigi R, Boero A, Argnani R, Caselli E, Zucchini S, Miriagou V, Mavromara P, Cilli M, Grossi MP, Balboni PG, Cassai E.
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.
Vaccine. 2005 Jan 4;23(7):865-72.

 

28- Zucchini S., Barbieri M., Simonato M. Alterations in seizures susceptibility and in seizure-induced plasticity following pharmacological and genetic manipulation of  the Fibroblast Growth Factor-2 system. Epilepsia. 2005; 46(Suppl.5):1-7.

 

29- Marti M, Mela F, Fantin M, Zucchini S, Brown J M, Witta J, Di Benedetto M, Buzas B, Reinscheid R, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox B M and  Morari M. Blockade of Nociceptin/Orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson’s disease. J of Neurosci, 2005 Oct; 25(42):9591–9601.

 

30-Rizzi A, Nazzaro C, Marzola GG, Zucchini S, Trapella C, Guerrini R, Zeilhofer HU, Regoli D, Calo' G. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences. Pain. 2006 Sep;124(1-2):100-8.

 

31-Rizzi A, Gavioli E, Marzola G, Spagnolo B, Zucchini S, Ciccocioppo R, Trapella C, Regoli D, Calo G. Related Articles, Pharmacological characterization of the nociceptin / orphanin FQ receptor antagonist SB-612111: in vivo studies. J Pharmacol Exp Ther. 2007 Jun;321(3):968-74.

 

32-Franceschetti S, Sancini G, Buzzi A, Zucchini S, Paradiso B, Magnaghi G, Frassoni C, Chikhladze M, Avanzini G, Simonato M. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Neurobiol Dis. 2007 Mar;25(3):675-85. 

 

 33-Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, Calo' G. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides. 2007 Jun;28(6):1229-39.

 

34-Rodi D, Zucchini S, Simonato M, Cifani C, Massi M, Polidori C.Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology (Berl). 2008 Mar;196(4):523-31.

 

35- Camarda V, Rizzi A, Ruzza C, Zucchini S, Marzola G, Marzola E, Guerrini R, Salvadori S, Reinscheid RK, Regoli D, Calò G In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. J Pharmacol Exp Ther. 2009 Feb;328(2):549-55.

 

36- Pignatelli A, Ackman JB, Vigetti D, Beltrami AP, Zucchini S, Belluzzi O. A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb.

Pflugers Arch. 2009 Feb;457(4):899-915.

 

37- Zucchini S, Buzzi A, Barbieri M, Rodi D, Paradiso B, Binaschi A, Coffin JD, Marzola A, Cifelli P, Belluzzi O, Simonato M. Fgf-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss. J Neurosci. 2008 Dec 3;28(49):13112-24.

38- Paradiso B, Marconi P, Zucchini S, Berto E, Binaschi A, Bozac A, Buzzi A, Mazzuferi M, Magri E, Mora GN, Rodi D, Su T, Volpi I, Zanetti L, Marzola A, Manservigi R, Fabene PF, Simonato M. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci U S A. 2009; 106(17):7191-6.
 
39-Marti M, Sarubbo S, Latini F, Cavallo M, Eleopra R, Biguzzi S, Lettieri C, Conti C, Simonato M, Zucchini S, Quatrale R, Sensi M, Candeletti S, Romualdi P, Morari M. Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease. Mov Disord. 2010; 25(11):1723-32.
 
40-Bovolenta R, Zucchini S, Paradiso B, Rodi D, Merigo F, Navarro Mora G, Osculati F, Berto E, Marconi P, Marzola A, Fabene PF, Simonato M. Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. J Neuroinflammation. 2010;7:81.
 
 
 
 
Capitoli di Libri Internazionali:
 
Simonato M., Zucchini S., Binaschi A.. Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). in „Encyclopedia of Basic Epilepsy Research“ Schwartzkroin P. ed. pp.1085-1089. Elsiever. Oxford Uk 2009.
 
Simonato M., Zucchini S. Fibroblast Growth Factor-2 (FGF-2). in „Encyclopedia of Basic Epilepsy Research“ Schwartzkroin P. ed. pp. 916-921 Elsiever. Oxford Uk 2009.